RecallDepth
Class II Ongoing

Oxacillin for Injection, USP, 10 gram per pharmacy Bulk Package bottle, For Intravenous Use, Rx only, packaged as a) NDC 25021-163-99 and b) novaplus NDC 25021-163-68, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. Made in India.

This recall is currently active, issued August 2, 2023. It was issued by Sagent Pharmaceuticals.

Company
Sagent Pharmaceuticals
Recall Initiated
July 11, 2023
Posted
August 2, 2023
Recall Number
D-0937-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
760 bottles
Firm Location
Schaumburg, IL, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility

Distribution

Nationwide in the USA

Lot / Code Info

Lot: a) OXT202, exp 5/31/2025; OXT203, exp 5/31/2025; OXT301, exp 12/31/2025; b) OXT205, exp 6/30/2025; OXT204, exp 5/31/2025

More recalls by Sagent Pharmaceuticals

View all recalls by this company →

Other recent Class II Drug recalls